4D Molecular Therapeutics (FDMT)
US Market

4D Molecular Therapeutics (FDMT) Stock Price & Analysis


FDMT Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$5.32 - $26.49
Previous Close$17.61
Average Volume (3M)569.98K
Market Cap
Enterprise Value$552.83M
Total Cash (Recent Filing)$200.45M
Total Debt (Recent Filing)$15.68M
Price to Earnings (P/E)-5.2
Aug 10, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.38
Shares Outstanding33,260,378
10 Day Avg. Volume534,912
30 Day Avg. Volume569,976
Standard Deviation0.38
Financial Highlights & Ratios
Price to Book (P/B)2.88
Price to Sales (P/S)1965.49
Price to Cash Flow (P/CF)-5.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue250.38
Enterprise Value/Gross Profit176.68
Enterprise Value/Ebitda-5.03
Price Target Upside94.49% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was 4D Molecular Therapeutics’s price range in the past 12 months?
4D Molecular Therapeutics lowest stock price was $5.32 and its highest was $26.49 in the past 12 months.
    What is 4D Molecular Therapeutics’s market cap?
    Currently, no data Available
    When is 4D Molecular Therapeutics’s upcoming earnings report date?
    4D Molecular Therapeutics’s upcoming earnings report date is Aug 10, 2023 which is in 74 days.
      How were 4D Molecular Therapeutics’s earnings last quarter?
      4D Molecular Therapeutics released its earnings results on May 10, 2023. The company reported -$0.88 earnings per share for the quarter, beating the consensus estimate of -$0.893 by $0.013.
        Is 4D Molecular Therapeutics overvalued?
        According to Wall Street analysts 4D Molecular Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does 4D Molecular Therapeutics pay dividends?
          4D Molecular Therapeutics does not currently pay dividends.
          What is 4D Molecular Therapeutics’s EPS estimate?
          4D Molecular Therapeutics’s EPS estimate is -$0.8.
            How many shares outstanding does 4D Molecular Therapeutics have?
            4D Molecular Therapeutics has 41,885,380 shares outstanding.
              What happened to 4D Molecular Therapeutics’s price movement after its last earnings report?
              4D Molecular Therapeutics reported an EPS of -$0.88 in its last earnings report, beating expectations of -$0.893. Following the earnings report the stock price went up 1.847%.
                Which hedge fund is a major shareholder of 4D Molecular Therapeutics?
                Among the largest hedge funds holding 4D Molecular Therapeutics’s share is Viking Global Investors LP. It holds 4D Molecular Therapeutics’s shares valued at 68M.


                  4D Molecular Therapeutics Stock Smart Score

                  The 4D Molecular Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  4D Molecular Therapeutics

                  4D Molecular Therapeutics Inc is a development stage precision gene therapy company. It engages in developing a broad pipeline of transformative gene therapy product candidates designed to treat patients suffering from lysosomal storage diseases, lung diseases, muscular dystrophies, and ophthalmic diseases. The AAV vectors are designed to provide targeted delivery by routine clinical routes, efficient transduction, reduced immunogenicity and resistance to pre-existing antibodies which enable to develop gene therapies.


                  Top 5 ETFs holding FDMT

                  Market Value
                  Smart Score
                  iShares Core S&P Total U.S. Stock Market ETF
                  iShares NASDAQ US Biotechnology UCITS ETF
                  Schwab U.S. Broad Market ETF
                  Fidelity MSCI Health Care Index ETF
                  iShares Russell 3000 ETF
                  Up to five ETFs with an Outperform Smart Score that hold FDMT. The ETFs are listed according to market value of FDMT within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Gossamer Bio
                  Adicet Bio
                  PureTech Health

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis